Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (20421)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 26, 2021 (publication date) through Dec 1, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zippi M, Fiorino S, Budriesi R, Micucci M, Corazza I, Pica R, de Biase D, Gallo CG, Hong W. Paradoxical relationship between proton pump inhibitors and COVID-19: A systematic review and meta-analysis. World J Clin Cases 2021; 9(12): 2763-2777 [PMID: 33969059 DOI: 10.12998/wjcc.v9.i12.2763] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v9/i12/2763.htm |
| Number | Citing Articles |
| 1 |
Filippo Vernia, Hassan Ashktorab, Nicola Cesaro, Sabrina Monaco, Susanna Faenza, Emanuele Sgamma, Angelo Viscido, Giovanni Latella. COVID-19 and Gastrointestinal Tract: From Pathophysiology to Clinical Manifestations. Medicina 2023; 59(10): 1709 doi: 10.3390/medicina59101709
|
| 2 |
T. E. Kugler, I. S. Malovichko, V. B. Gnilitskaya, A. L. Khristulenko, N. F. Yarovaya. Proton Pump Inhibitors in the COVID-19 Pandemic. The Russian Archives of Internal Medicine 2022; 12(4): 245 doi: 10.20514/2226-6704-2022-12-4-245-253
|
| 3 |
Verena Schöning, Felix Hammann. Drug-Disease Severity and Target-Disease Severity Interaction Networks in COVID-19 Patients. Pharmaceutics 2022; 14(9): 1828 doi: 10.3390/pharmaceutics14091828
|
| 4 |
M.A. Shokri, T. Moghadam Fard, T. Ramim, A. Hejrati, L. Hejrati, M. Mokhtare. What is the role of proton pump inhibitors consumption on the clinical presentation and severity of COVID-19 infection?. Annales Pharmaceutiques Françaises 2023; 81(2): 210 doi: 10.1016/j.pharma.2022.08.013
|
| 5 |
Lin-xi Sun, Yuan-yuan Li, Yan-ming Xie. Efficacy and safety of Tongmai Jiangtang capsule combined with conventional therapy in the treatment of diabetic peripheral neuropathy: a systematic review and meta-analysis. Frontiers in Neurology 2023; 14 doi: 10.3389/fneur.2023.1100327
|
| 6 |
|
| 7 |
Fabio Magurano, Matteo Micucci, Domenico Nuzzo, Melissa Baggieri, Pasquale Picone, Silvia Gioacchini, Raoul Fioravanti, Paola Bucci, Maedeh Kojouri, Michele Mari, Michele Retini, Roberta Budriesi, Laura Beatrice Mattioli, Ivan Corazza, Valentina Di Liberto, Luigi Todaro, Roberto Giuseppetti, Emilio D’Ugo, Antonella Marchi, Marisabel Mecca, Maurizio D’Auria. A potential host and virus targeting tool against COVID-19: Chemical characterization, antiviral, cytoprotective, antioxidant, respiratory smooth muscle relaxant effects of Paulownia tomentosa Steud. Biomedicine & Pharmacotherapy 2023; 158: 114083 doi: 10.1016/j.biopha.2022.114083
|
| 8 |
Valentina Giardini, Carlo Gambacorti-Passerini, Marco Casati, Andrea Carrer, Patrizia Vergani. Analogies between COVID-19 and Preeclampsia: Focus on Therapies. International Journal of Translational Medicine 2023; 3(2): 203 doi: 10.3390/ijtm3020015
|
| 9 |
Hong-Bae Kim, Jung-Ha Kim, Bethany J. Wolf. Acid suppressant use in association with incidence and severe outcomes of COVID-19: a systematic review and meta-analysis. European Journal of Clinical Pharmacology 2022; 78(3): 383 doi: 10.1007/s00228-021-03255-1
|